180 related articles for article (PubMed ID: 23756374)
21. When to start antiretroviral therapy in resource-limited settings.
Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
[TBL] [Abstract][Full Text] [Related]
22. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
23. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
Fox MP; Sanne IM; Conradie F; Zeinecker J; Orrell C; Ive P; Rassool M; Dehlinger M; van der Horst C; McIntyre J; Wood R
AIDS; 2010 Aug; 24(13):2041-50. PubMed ID: 20613459
[TBL] [Abstract][Full Text] [Related]
24. Change of treatment guidelines and evolution of ART initiation in rural South Africa: data of a large HIV care and treatment programme.
Plazy M; Dabis F; Naidu K; Orne-Gliemann J; Barnighausen T; Dray-Spira R
BMC Infect Dis; 2015 Oct; 15():452. PubMed ID: 26497054
[TBL] [Abstract][Full Text] [Related]
25. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
26. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
27. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
[TBL] [Abstract][Full Text] [Related]
28. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
[TBL] [Abstract][Full Text] [Related]
29. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.
Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Bärnighausen T; Bor J
Clin Infect Dis; 2022 Apr; 74(8):1350-1359. PubMed ID: 34309633
[TBL] [Abstract][Full Text] [Related]
30. Impact of nurse-delivered community-based CD4 services on facilitating pre-ART care in rural South Africa.
Kompala T; Moll AP; Mtungwa N; Brooks RP; Friedland GH; Shenoi SV
BMC Health Serv Res; 2016 Aug; 16(a):374. PubMed ID: 27515233
[TBL] [Abstract][Full Text] [Related]
31. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.
Charalambous S; Grant AD; Innes C; Hoffmann CJ; Dowdeswell R; Pienaar J; Fielding KL; Churchyard GJ
AIDS; 2010 Nov; 24 Suppl 5(0 5):S5-13. PubMed ID: 21079429
[TBL] [Abstract][Full Text] [Related]
32. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study.
Bor J; Ahmed S; Fox MP; Rosen S; Meyer-Rath G; Katz IT; Tanser F; Pillay D; Bärnighausen T
PLoS One; 2017; 12(6):e0178249. PubMed ID: 28617805
[TBL] [Abstract][Full Text] [Related]
33. Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012-2017) Based on Evolving National Policies in Rural Mozambique.
Arinze F; Gong W; Green AF; De Schacht C; Carlucci JG; Silva W; Claquin G; Tique JA; Stefanutto M; Graves E; Van Rompaey S; Alvim MFS; Tomo S; Moon TD; Wester CW
AIDS Res Hum Retroviruses; 2020 Jan; 36(1):39-47. PubMed ID: 31359762
[TBL] [Abstract][Full Text] [Related]
34. The effect of a maturing antiretroviral program on early mortality for patients with advanced immune-suppression in Soweto, South Africa.
Otwombe KN; Laher F; Tutu-Gxashe T; Gray G; Mohapi L
PLoS One; 2013; 8(11):e81538. PubMed ID: 24312317
[TBL] [Abstract][Full Text] [Related]
35. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
[TBL] [Abstract][Full Text] [Related]
36. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.
Odhiambo JO; Kellogg TA; Kim AA; Ng'ang'a L; Mukui I; Umuro M; Mohammed I; De Cock KM; Kimanga DO; Schwarcz S;
J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S116-22. PubMed ID: 24732815
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
39. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa.
Hoffmann CJ; Schomaker M; Fox MP; Mutevedzi P; Giddy J; Prozesky H; Wood R; Garone DB; Egger M; Boulle A;
J Acquir Immune Defic Syndr; 2013 May; 63(1):34-41. PubMed ID: 23344547
[TBL] [Abstract][Full Text] [Related]
40. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
